NEW IGT Policy Resources Available
Gene therapies offer a completely new way of treating a range of serious diseases. But before we can realize their full potential, a...
NEW IGT Policy Resources Available
IGT Recognizes Rare Disease Day
IGT Comments on CMS Final Rule on Value-based Purchasing Arrangements
Patient Perspective: Erin Frey with CureDuchenne
Patient Perspective: Cure SMA
Dr. Peter Marks Clarifies FDA’s Approach to Gene Therapies After CRL for Hemophilia A Treatment
Patient Perspective: EveryLife Foundation for Rare Diseases
IGT Comments on CMS Proposed Rule on Value-based Purchasing Arrangements